Evaluating Site-Level Implementations of the HL7 FHIR Standard to Support eSource Data Exchange in Clinical Research

被引：9

作者：

Garza, Maryam Y. ^{[1
]}

Rutherford, Michael W. ^{[1
]}

Adagarla, Bhargav ^{[2
]}

Eisenstein, Eric ^{[2
]}

Kumar, Karan R. ^{[2
]}

Zimmerman, Kanecia O. ^{[2
]}

Topaloglu, Umit ^{[3
]}

Zozus, Meredith ^{[4
]}

机构：

[1] Univ Arkansas Med Sci, Little Rock, AR USA

[2] Duke Univ, Duke Clin Res Inst, Durham, NC USA

[3] Wake Forest Univ, Sch Med, Winston Salem, NC USA

[4] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA

来源：

PUBLIC HEALTH AND INFORMATICS, PROCEEDINGS OF MIE 2021 | 2021年 / 281卷

基金：

美国国家卫生研究院;

关键词：

HL7; FHIR; eSource; electronic health records; clinical research; interoperability; health information exchange; CHALLENGES;

D O I：

10.3233/SHTI210188

中图分类号：

TP39 [计算机的应用];

学科分类号：

081203 ; 0835 ;

摘要：

Direct extraction and use of electronic health record (EHR) data is a longterm and multifaceted endeavor that includes design, development, implementation and evaluation of methods and tools for semi-automating tasks in the research data collection process, including, but not limited to, medical record abstraction (MRA). A systematic mapping of study data elements was used to measure the coverage of the Health Level Seven (HL7((R))) Fast Healthcare Interoperability Resources (FHIR (R)) standard for a federally sponsored, pragmatic cardiovascular randomized controlled trial (RCT) targeting adults. We evaluated site-level implementations of the HL7((R)) FHIR (R) standard to investigate study- and site-level differences that could affect coverage and offer insight into the feasibility of a FHIR-based eSource solution for multicenter clinical research.

引用

页码：397 / 401

页数：5

共 14 条

[1]

CMS, 2020, CMS Interoperability and Patient Access final rule (CMS-9115-F).85 FR 25510(Final Rule)

[2] Innovation in the pharmaceutical industry: New estimates of R&D costs [J].